Yoo-Young Lee

Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004)

D. Suh, S. Shim, HeeSeung Kim, 2023, Cancer medicine.